EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pathogenesis of Chemical Leukoderma and Chemical‐Induced Vitiligo

Yasutaka Kuroda iD, Lingli Yang, Ichiro Katayama

The Journal of Dermatology · 2026

DOI: 10.1111/1346-8138.70060 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Dermatology, 2026. Verfasst von Yasutaka Kuroda und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pigmentation Research and Therapeutics, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan. Hauptthemen laut MEDLINE: Vitiligo, Hypopigmentation, Butanols. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leukoderma/vitiligo is a serious pigmentary disorder that notably impairs the patient's quality of life. In particular, chemical leukoderma (CL)/vitiligo refers to acquired depigmentation of the skin induced by exposure to certain chemicals. In this review, the term “CL” is defined as the temporary, localized loss of pigmentation at the site of direct chemical exposure. When the causative chemical is removed, these skin patches undergo re‐pigmentation, indicating the restoration of melanocytes to their original condition. However, when the chemical‐induced skin depigmentation does not recover after the chemical is removed, or when de novo depigmented lesions emerge, it is classified as chemical‐induced vitiligo. This condition indicates that, even after chemical removal, the mature melanocytes cannot recover because of factors including, but not limited to, autoimmunity, stem cell depletion, and unknown factors. In this review, we summarized the latest pathological findings for each condition, focusing on rhododendrol, which is known to induce both phenotypes and cause an outbreak, which affected nearly 20,000 patients in Japan and other Asian countries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitiligoHypopigmentationButanolsHumansMelanocytesSkinSkin Pigmentation

Stichwörter der Autor:innen

Rhododendrolanimal modelleukodermapigmentation disordersvitiligo

Substanzen

rhododendrolButanols

Autor:innen und Institutionen

  • Department of Pigmentation Research and Therapeutics, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
  • Cosmetic Products Research, Research and Development, Kao Corporation, Odawara, Japan.

ORCID-Profile: Yasutaka Kuroda

Zitieren

APA

Kuroda, Y., Yang, L., & Katayama, I. (2026). Pathogenesis of Chemical Leukoderma and Chemical‐Induced Vitiligo. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.70060

Vancouver

Kuroda Y, Yang L, Katayama I. Pathogenesis of Chemical Leukoderma and Chemical‐Induced Vitiligo. The Journal of Dermatology. 2026. doi:10.1111/1346-8138.70060

BibTeX
@article{Kuroda2026,
  author = {Kuroda, Yasutaka and Yang, Lingli and Katayama, Ichiro},
  title = {Pathogenesis of Chemical Leukoderma and Chemical‐Induced Vitiligo},
  journal = {The Journal of Dermatology},
  year = {2026},
  doi = {10.1111/1346-8138.70060}
}
Kostenlos starten →